Caplin Point Labs' subsidiary inks distribution pact with Xellia Pharma for 5 injectables in US
Posted by
www.biotecnika.org
The first product is expected to be launched shortly, while approvals
for the remaining are expected in the next 12-18 months, Caplin Point
Laboratories said in a BSE filing.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/caplin-point-labs-subsidiary-inks-distribution-pact-with-xellia-pharma-for-5-injectables-in-us/articleshow/76827893.cms
Subscribe to:
Post Comments (Atom)
Post a Comment